Allergan PLC’s Charm-and-Merger Offensive (AGN)

Allergan has switched strategies, and now wants to buy potential blockbuster drugs. But does AGN CEO Brent Saunders have an eye for the new game? More 

Allergan plc Ordinary Shares: What Is AGN Getting for Its Billion Dollars?

Allergen (AGN) is in a buying mood, and can afford to buy Tobira (TBRA). But, that doesn't mean there's a big payback for the investment. More 

Allergan plc Ordinary Shares (AGN) Up on $639M Buyout of Vitae Pharmaceuticals Inc (VTAE)

Allergan plc Ordinary Shares (NYSE:AGN) is buying Vitae Pharmaceuticals Inc. (NASDAQ:VTAE) to ramp up its dermatology treatment offerings. More 

GW Pharmaceuticals PLC- ADR (GWPH) Boards the Buyout Rumor Mill

GW Pharma (GWPH) is allegedly working with an investment bank after several companies expressed interest in a transaction. More 

PFE, AZN: Pfizer Inc. to Buy AstraZeneca plc (ADR)’s Antibiotic Business

Pfizer (PFE) has announced that it will be acquiring part of AstraZeneca's (AZN) antibiotic business outside the US for $725 million. More 

7 Stocks the Smart Money Loves … Or Hates

What is the smart money buying and selling lately? A look at the newest opinions on stocks like Apple, Facebook ... and an Irish aircraft leaser? More 

Why Allergan plc Ordinary Shares (AGN), AMN Healthcare Services, Inc. (AHS) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks

Owners of Bristol-Myers Squibb (BMY), Allergan (AGN) and AMN Healthcare Services (AHS) are wishing the weekend lasted one more day today. More